Lung emphysema and impaired macrophage elastase clearance in mucolipin 3 deficient mice

Author:

Spix Barbara,Butz Elisabeth S.,Chen Cheng-Chang,Rosato Anna Scotto,Tang Rachel,Jeridi Aicha,Kudrina VeronikaORCID,Plesch Eva,Wartenberg Philipp,Arlt Elisabeth,Briukhovetska Daria,Ansari MeshalORCID,Günsel Gizem Günes,Conlon Thomas M.ORCID,Wyatt AmandaORCID,Wetzel Sandra,Teupser Daniel,Holdt Lesca M.,Ectors FabienORCID,Boekhoff Ingrid,Boehm Ulrich,García-Añoveros JaimeORCID,Saftig PaulORCID,Giera MartinORCID,Kobold SebastianORCID,Schiller Herbert B.ORCID,Zierler Susanna,Gudermann Thomas,Wahl-Schott ChristianORCID,Bracher FranzORCID,Yildirim Ali ÖnderORCID,Biel MartinORCID,Grimm ChristianORCID

Abstract

AbstractLung emphysema and chronic bronchitis are the two most common causes of chronic obstructive pulmonary disease. Excess macrophage elastase MMP-12, which is predominantly secreted from alveolar macrophages, is known to mediate the development of lung injury and emphysema. Here, we discovered the endolysosomal cation channel mucolipin 3 (TRPML3) as a regulator of MMP-12 reuptake from broncho-alveolar fluid, driving in two independently generated Trpml3−/− mouse models enlarged lung injury, which is further exacerbated after elastase or tobacco smoke treatment. Mechanistically, using a Trpml3IRES-Cre/eR26-τGFP reporter mouse model, transcriptomics, and endolysosomal patch-clamp experiments, we show that in the lung TRPML3 is almost exclusively expressed in alveolar macrophages, where its loss leads to defects in early endosomal trafficking and endocytosis of MMP-12. Our findings suggest that TRPML3 represents a key regulator of MMP-12 clearance by alveolar macrophages and may serve as therapeutic target for emphysema and chronic obstructive pulmonary disease.

Funder

Deutsche Forschungsgemeinschaft

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry,Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3